GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » Total Long-Term Liabilities

SynBiotic SE (XTER:SBX) Total Long-Term Liabilities : €11.57 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is SynBiotic SE Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. SynBiotic SE's Total Long-Term Liabilities for the quarter that ended in Dec. 2023 was €11.57 Mil.

SynBiotic SE Total Long-Term Liabilities Historical Data

The historical data trend for SynBiotic SE's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynBiotic SE Total Long-Term Liabilities Chart

SynBiotic SE Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Liabilities
Get a 7-Day Free Trial - 0.32 18.95 12.09 11.57

SynBiotic SE Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only 1.00 18.95 1.85 12.09 11.57

SynBiotic SE Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

SynBiotic SE Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of SynBiotic SE's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

SynBiotic SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » Total Long-Term Liabilities
Comparable Companies
XTER:B8FK FRA:HIGH FRA:APPH ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA XSWX:SDZ NSE:DIVISLAB NBIX SZSE:000538 ITCI VTRS HKSE:03692 NSE:TORNTPHARM TSE:4507 BOM:543904
Traded in Other Exchanges
N/A
Address
Barer Strasse 7, Munich, BY, DEU, 80333
Website
https://www.synbiotic.com
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.
Executives
Daniel Kruse Geschäftsführender Direktor

SynBiotic SE Headlines

No Headlines